Back to Journals » Neuropsychiatric Disease and Treatment » Volume 17

Identifying Early Neuropsychological Indicators of Cognitive Involvement in Multiple Sclerosis

Authors Gromisch ES, Dhari Z

Received 12 November 2020

Accepted for publication 22 January 2021

Published 5 February 2021 Volume 2021:17 Pages 323—337

DOI https://doi.org/10.2147/NDT.S256689

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Roger Pinder


Elizabeth S Gromisch,1– 4 Zaenab Dhari1,2

1Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, USA; 2Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA; 3Department of Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA; 4Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, USA

Correspondence: Elizabeth S Gromisch 490 Blue Hills Avenue, Hartford, CT, 06112, USA
Tel +860-714-2154
Fax +860-714-8933
Email elizabeth.gromisch@trinityhealthofne.org

Abstract: Multiple sclerosis (MS) is a debilitating disease of the central nervous system that is most commonly seen in early to middle adulthood, although it can be diagnosed during childhood or later in life. While cognitive impairment can become more prevalent and severe as the disease progresses, signs of cognitive involvement can be apparent in the early stages of the disease. In this review, we discuss the prevalence and types of cognitive impairment seen in early MS, including the specific measures used to identify them, as well as the challenges in characterizing their frequency and progression. In addition to examining the progression of early cognitive involvement over time, we explore the clinical factors associated with early cognitive involvement, including demographics, level of physical disability, disease modifying therapy use, vocational status, and psychological and physical symptoms. Given the prevalence and functional impact these impairments can have for persons with MS, considerations for clinicians are provided, such as the role of early cognitive screenings and the importance of comprehensive neuropsychological assessments.

Keywords: multiple sclerosis, early cognitive impairment, neuropsychological assessment, modifying factors

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]